End-of-day quote
Mexican S.E.
06:00:00 2024-05-30 pm EDT
|
5-day change
|
1st Jan Change
|
875
MXN
|
+0.59%
|
|
+1.74%
|
+75.00%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
23,923
|
26,244
|
33,061
|
33,429
|
48,391
|
84,551
|
-
|
-
|
Enterprise Value (EV)
1 |
23,368
|
24,215
|
30,708
|
27,704
|
48,391
|
76,009
|
72,455
|
68,352
|
P/E ratio
|
14.7
x
|
13.6
x
|
13.3
x
|
11.1
x
|
11.4
x
|
-
|
-
|
-
|
Yield
|
1.18%
|
-
|
3%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.39
x
|
0.36
x
|
0.39
x
|
0.34
x
|
0.44
x
|
0.69
x
|
0.63
x
|
0.57
x
|
EV / Revenue
|
0.38
x
|
0.33
x
|
0.36
x
|
0.28
x
|
0.44
x
|
0.62
x
|
0.54
x
|
0.46
x
|
EV / EBITDA
|
6.23
x
|
5.09
x
|
4.89
x
|
3.58
x
|
5.21
x
|
7.16
x
|
6.07
x
|
5.13
x
|
EV / FCF
|
179
x
|
14.8
x
|
49.4
x
|
-
|
-
|
21.3
x
|
13.9
x
|
11.3
x
|
FCF Yield
|
0.56%
|
6.77%
|
2.02%
|
-
|
-
|
4.69%
|
7.18%
|
8.88%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
97,646
|
97,396
|
97,396
|
97,156
|
96,781
|
96,631
|
-
|
-
|
Reference price
2 |
245.0
|
269.5
|
339.4
|
344.1
|
500.0
|
875.0
|
875.0
|
875.0
|
Announcement Date
|
2/26/20
|
2/26/21
|
2/23/22
|
2/27/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
61,884
|
73,314
|
84,794
|
97,918
|
109,374
|
121,983
|
134,801
|
148,312
|
EBITDA
1 |
3,751
|
4,759
|
6,281
|
7,730
|
9,292
|
10,615
|
11,929
|
13,323
|
EBIT
1 |
3,028
|
3,880
|
5,217
|
6,315
|
7,923
|
9,157
|
10,272
|
11,570
|
Operating Margin
|
4.89%
|
5.29%
|
6.15%
|
6.45%
|
7.24%
|
7.51%
|
7.62%
|
7.8%
|
Earnings before Tax (EBT)
|
2,633
|
3,367
|
4,670
|
5,602
|
7,116
|
-
|
-
|
-
|
Net income
1 |
1,710
|
2,030
|
2,622
|
-
|
4,501
|
5,386
|
6,030
|
6,833
|
Net margin
|
2.76%
|
2.77%
|
3.09%
|
-
|
4.11%
|
4.42%
|
4.47%
|
4.61%
|
EPS
|
16.67
|
19.78
|
25.55
|
30.99
|
43.87
|
-
|
-
|
-
|
Free Cash Flow
1 |
130.6
|
1,639
|
621
|
-
|
-
|
3,567
|
5,204
|
6,071
|
FCF margin
|
0.21%
|
2.24%
|
0.73%
|
-
|
-
|
2.92%
|
3.86%
|
4.09%
|
FCF Conversion (EBITDA)
|
3.48%
|
34.45%
|
9.89%
|
-
|
-
|
33.6%
|
43.62%
|
45.57%
|
FCF Conversion (Net income)
|
7.64%
|
80.75%
|
23.69%
|
-
|
-
|
66.23%
|
86.3%
|
88.85%
|
Dividend per Share
|
2.900
|
-
|
10.20
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/26/20
|
2/26/21
|
2/23/22
|
2/27/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q2
|
2023 Q3
|
---|
Net sales
1 |
21,912
|
23,487
|
23,757
|
24,451
|
26,223
|
27,087
|
27,251
|
EBITDA
1 |
1,800
|
1,869
|
1,815
|
2,204
|
2,150
|
2,051
|
2,273
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
703.4
|
-
|
762.7
|
826
|
840
|
1,038
|
1,212
|
Net margin
|
3.21%
|
-
|
3.21%
|
3.38%
|
3.2%
|
3.83%
|
4.45%
|
EPS
2 |
6.850
|
7.310
|
7.430
|
8.050
|
8.180
|
10.12
|
11.82
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/23/22
|
4/29/22
|
7/27/22
|
10/28/22
|
2/27/23
|
7/27/23
|
10/26/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
555
|
2,029
|
2,353
|
5,725
|
-
|
8,542
|
12,096
|
16,199
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
131
|
1,639
|
621
|
-
|
-
|
3,567
|
5,204
|
6,071
|
ROE (net income / shareholders' equity)
|
12.9%
|
13.7%
|
15.8%
|
30.8%
|
-
|
21.9%
|
21.3%
|
21.9%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
21.00
|
28.00
|
23.30
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
2,027
|
1,553
|
1,767
|
-
|
-
|
1,538
|
822
|
852
|
Capex / Sales
|
3.27%
|
2.12%
|
2.08%
|
-
|
-
|
1.26%
|
0.61%
|
0.57%
|
Announcement Date
|
2/26/20
|
2/26/21
|
2/23/22
|
2/27/23
|
2/27/24
|
-
|
-
|
-
|
Average target price
1,400
MXN Spread / Average Target +60.00% Consensus |
1st Jan change
|
Capi.
|
---|
| +75.00% | 4.96B | | -37.88% | 13.99B | | -33.12% | 10.67B | | +12.54% | 6.29B | | -11.17% | 5.88B | | -4.38% | 4.54B | | -9.20% | 3.74B | | -19.40% | 3.16B | | -12.15% | 2.85B | | -12.99% | 2.53B |
Other Drug Retailers
|